Key Events This Week
10 Aug: Stock opens at Rs.853.35, gaining 1.49%
11 Aug: New 52-week and all-time high intraday peak of Rs.897.90
12 Aug: Minor correction with a 1.55% decline
14 Aug: Week closes at Rs.890.25, up 1.78% on the day
10 August 2026: Positive Start with 1.49% Gain
Anthem Biosciences began the week on a positive note, closing at Rs.853.35, up Rs.12.55 or 1.49% from the previous Friday’s close of Rs.840.80. This gain outpaced the Sensex’s modest 0.09% rise to 37,131.97. The volume of 98,613 shares indicated steady investor interest. The stock traded above all key moving averages, signalling early bullish momentum that set the tone for the week.
11 August 2026: Breakout to New 52-Week and All-Time Highs
On 11 August, Anthem Biosciences surged impressively, hitting an intraday high of Rs.897.90, a new 52-week and all-time peak. The stock closed at Rs.891.80, up Rs.38.45 or 4.51%, significantly outperforming the Sensex which declined 0.28% to 37,029.82. This 5.02% intraday surge was accompanied by a sharp increase in volume to 186,096 shares, with delivery volumes rising by over 60% compared to the 5-day average, indicating strong shareholder participation.
The stock’s technical momentum shifted decisively bullish this day, supported by positive MACD and Bollinger Bands signals on weekly charts. Despite some mixed signals from the KST indicator, the overall trend was upgraded from mildly bullish to bullish. Anthem’s premium valuation metrics, including a trailing P/E of 81x and EV/EBITDA of 59.50x, reflect investor confidence in its growth prospects despite a modest dividend yield of 0.23%.
Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.
- - Strong fundamental track record
- - Consistent growth trajectory
- - Reliable price strength
12 August 2026: Minor Correction Amid Lower Volume
Following the strong rally, the stock experienced a mild pullback on 12 August, closing at Rs.877.95, down Rs.13.85 or 1.55%. This decline came on reduced volume of 59,516 shares, suggesting a temporary profit-taking phase rather than a reversal of trend. The Sensex also declined by 0.17% to 36,967.15, reflecting broader market weakness. Despite the dip, Anthem remained well above all major moving averages, maintaining its bullish technical posture.
13 August 2026: Consolidation with Slight Decline
The stock continued to consolidate on 13 August, slipping 0.38% to close at Rs.874.65 on volume of 72,974 shares. The Sensex rebounded slightly, gaining 0.16% to 37,024.45. Technical indicators remained supportive, with the stock holding above key support levels and the weekly MACD continuing to signal positive momentum. This consolidation phase may have allowed the stock to digest recent gains and prepare for further advances.
Anthem Biosciences Ltd or something better? Our SwitchER feature analyzes this mid-cap stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
14 August 2026: Week Closes Strong with 1.78% Gain
Anthem Biosciences ended the week on a positive note, gaining Rs.15.60 or 1.78% to close at Rs.890.25 on relatively low volume of 31,083 shares. The Sensex declined 0.17% to 36,962.93, underscoring the stock’s continued outperformance. The closing price was just below the week’s intraday high of Rs.897.90, confirming sustained investor interest and technical strength. The stock’s weekly gain of 5.88% contrasted sharply with the Sensex’s 0.37% decline, highlighting Anthem’s resilience amid a challenging market environment.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-08-10 | Rs.853.35 | +1.49% | 37,131.97 | +0.09% |
| 2026-08-11 | Rs.891.80 | +4.51% | 37,029.82 | -0.28% |
| 2026-08-12 | Rs.877.95 | -1.55% | 36,967.15 | -0.17% |
| 2026-08-13 | Rs.874.65 | -0.38% | 37,024.45 | +0.16% |
| 2026-08-14 | Rs.890.25 | +1.78% | 36,962.93 | -0.17% |
Key Takeaways from the Week
Strong Outperformance: Anthem Biosciences outpaced the Sensex by 6.25% this week, reflecting robust demand and investor confidence despite broader market weakness.
Technical Momentum Shift: The stock’s technical trend upgraded to bullish, supported by MACD, Bollinger Bands, and moving averages, signalling sustained upward momentum.
Volume and Delivery Trends: Elevated delivery volumes on 11 August confirmed strong shareholder participation during the breakout to new highs.
Valuation and Quality Metrics: Despite premium valuation multiples, the company’s solid growth rates, strong interest coverage, and negligible debt underpin its quality profile.
Short-Term Volatility: Minor corrections on 12 and 13 August suggest healthy profit-taking and consolidation rather than a reversal.
Conclusion
Anthem Biosciences Ltd demonstrated a compelling performance during the week of 10–14 August 2026, marked by a 5.88% price gain and a new all-time high. The stock’s ability to buck the broader market’s decline, combined with a bullish technical upgrade and strong volume participation, highlights its resilience and underlying strength. While valuation remains elevated, the company’s consistent growth metrics and financial health provide a solid foundation. Investors should note the healthy consolidation phases as part of a constructive price pattern. Overall, Anthem Biosciences remains a noteworthy mid-cap stock within the Pharmaceuticals & Biotechnology sector, delivering superior returns relative to the Sensex in a challenging market environment.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
